The proposed Bone Cells and Signaling Core will enable participating investigators to pursue new lines of research in skeletal biology by using state-of-the-art technologies for bone cell isolation and functional assessment, and by advancing their knowledge of how such systems can be applied to problems in the field. The proposed Core will bring together the expertise and acumen of the two Co-Directors Dr. Pajevic Divieti and Dr. Gardella, and powerful new research approaches and assay systems to make for a synergistic resource that will enrich and catalyze the scientific advances of participating investigators. The Core will enable investigators to obtain directly from skeletal tissue, specific types of cells, such as osteoblasts and osteocytes, in purified form, and to propagate these cells for further detailed study. Also enabled will be the means to knock-down specific genes of interest in these cells using shRNA technologies. The Core will further enable analyses of multiple signal transduction and sub-cellular molecular trafficking mechanisms that operate in such cells using sensitive new biochemical assays, high throughput plate reader technologies, and real-time, high-resolution microscopy approaches. As the Core evolves, it will seek to enable and apply new methods, such as CRISPR and TALON technologies to site-specifically alter target genes in cultured cells, scaffolding methods to grow and assay skeletal cells in three dimensions, and multiarray signaling assays to assess novel drug/modulator action, such as biased agonism and signaling selectivity. Each service provided by the Core will be rigorously controlled for quality performance and reliability. The Core will conduct hands-on training sessions by which investigators can be mentored and taught how to perform assays and cell manipulations on their own. It will also establish a seminar series by which new methodologies, approaches, and related scientific progress can be presented and discussed. By providing these services and functions at efficient costs, with high quality, and with rich education, the Core will reduce research barriers for established and junior investigators, and thus help open new lines of investigation and discovery in the skeletal field.

Public Health Relevance

The proposed research Core will enable and facilitate new research directions and open new opportunity for discovery in the field of skeletal biology. The Core will thus advance the careers of multiple participating investigators and lead to knew understanding of how skeletal systems function in human health.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
1P30AR066261-01
Application #
8708416
Study Section
Special Emphasis Panel (ZAR1-XZ (M1))
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
1
Fiscal Year
2014
Total Cost
$228,015
Indirect Cost
$96,972
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Miranda, Daniel L; Putman, Melissa; Kandah, Ruby et al. (2016) A pediatric animal model to evaluate the effects of disuse on musculoskeletal growth and development. J Biomech 49:3549-3554
Liu, Eva S; Martins, Janaina S; Raimann, Adalbert et al. (2016) 1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression. J Bone Miner Res 31:929-39
Kim, Sang Wan; Lu, Yanhui; Williams, Elizabeth A et al. (2016) Sclerostin Antibody Administration Converts Bone Lining Cells into Active Osteoblasts. J Bone Miner Res :
Wein, Marc N; Liang, Yanke; Goransson, Olga et al. (2016) SIKs control osteocyte responses to parathyroid hormone. Nat Commun 7:13176
Fan, Yi; Bi, Ruiye; Densmore, Michael J et al. (2016) Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis. FASEB J 30:428-40
Eda, Homare; Santo, Loredana; Wein, Marc N et al. (2016) Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease. J Bone Miner Res 31:1225-34
Mirzamohammadi, Fatemeh; Papaioannou, Garyfallia; Inloes, Jennifer B et al. (2016) Polycomb repressive complex 2 regulates skeletal growth by suppressing Wnt and TGF-β signalling. Nat Commun 7:12047
Hattersley, Gary; Dean, Thomas; Corbin, Braden A et al. (2016) Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling. Endocrinology 157:141-9
Song, Lige; Papaioannou, Garyfallia; Zhao, Hengguang et al. (2016) The Vitamin D Receptor Regulates Tissue Resident Macrophage Response to Injury. Endocrinology 157:4066-4075
Liu, Eva S; Raimann, Adalbert; Chae, Byongsoo Timothy et al. (2016) c-Raf promotes angiogenesis during normal growth plate maturation. Development 143:348-55

Showing the most recent 10 out of 13 publications